HAVCR2 and neoplasm: Finally, in T cell-deficient mice, pharmacological inhibition of MAPK reversed unintended Tim-3 Ab-mediated tumorigenesis, while in T cell-competent hosts, Tim-3 interference boosted the desirable anti-tumour action.